Loomis, Sayles & Company
EVH icon

Loomis, Sayles & Company’s Evolent Health EVH Stock Holding History

Loomis, Sayles & Company’s Portfolio EVH Stock Details EVH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-1,609,013
Closed -$30.8M – 708
2024
Q2 		$30.8M Sell
1,609,013
-502,102
-24% -$12.8M 0.04% 183
2024
Q1 		$69.2M Buy
2,111,115
+115,503
+6% +$3.69M 0.1% 89
2023
Q4 		$65.9M Sell
1,995,612
-49,001
-2% -$1.39M 0.1% 92
2023
Q3 		$55.7M Sell
2,044,613
-196,807
-9% -$5.47M 0.1% 102
2023
Q2 		$67.9M Sell
2,241,420
-37,407
-2% -$1.21M 0.11% 89
2023
Q1 		$73.9M Buy
2,278,827
+362,544
+19% +$11.5M 0.13% 82
2022
Q4 		$53.8M Sell
1,916,283
-712,701
-27% -$20.4M 0.11% 104
2022
Q3 		$94.5M Buy
2,628,984
+114,793
+5% +$4.04M 0.19% 66
2022
Q2 		$77.2M Sell
2,514,191
-12,768
-0.5% -$372K 0.14% 69
2022
Q1 		$81.6M Buy
2,526,959
+544,667
+27% +$14.3M 0.11% 79
2021
Q4 		$54.9M Buy
1,982,292
+394,503
+25% +$11.3M 0.07% 133
2021
Q3 		$49.2M Buy
1,587,789
+714,787
+82% +$17.2M 0.06% 148
2021
Q2 		$18.4M Buy
+873,002
New +$17.5M 0.02% 314
2019
Q1 		– Sell
-767,446
Closed -$15.3M – 803
2018
Q4 		$15.3M Buy
+767,446
New +$17.8M 0.04% 218
2017
Q1 		– Sell
-400,607
Closed -$5.93M – 977
2016
Q4 		$5.93M Sell
400,607
-172,205
-30% -$3.39M 0.01% 506
2016
Q3 		$14.1M Buy
+572,812
New +$13.4M 0.04% 357
2015
Q4 		– Sell
-49,241
Closed -$786K – 1070
2015
Q3 		$786K Buy
49,241
+17,192
+54% +$335K ﹤0.01% 571
2015
Q2 		$625K Buy
+32,049
New +$597K ﹤0.01% 597

Other funds holding EVH

Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
William Blair Investment Management
William Blair Investment Management Chicago, Illinois $30.3B AUM 33.75% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
EC
Engaged Capital Newport Beach, California $303M AUM 2.09% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return

Loomis, Sayles & Company's EVH Position: Q3 2024 in Review

Loomis, Sayles & Company sold out of Evolent Health (EVH) in Q3 2024, closing a stake of 1,609,013 shares — an estimated $30.8M sold.

Loomis, Sayles & Company first reported a position in EVH in Q2 2015 and held it in 18 quarters. The position peaked at $94.5M in Q3 2022. 262 funds tracked by Wall St. Rank hold EVH as of Q3 2024.

  • Loomis, Sayles & Company reported no remaining Evolent Health position as of Q3 2024 after selling out during the quarter.
  • Loomis, Sayles & Company sold 1,609,013 Evolent Health shares in Q3 2024, an estimated $30.8M.
  • Loomis, Sayles & Company first reported a position in Evolent Health in Q2 2015 and held it in 18 quarters.
  • Loomis, Sayles & Company's Evolent Health position peaked at $94.5M in Q3 2022.
  • 262 funds tracked by Wall St. Rank held Evolent Health as of Q3 2024.

Based on Loomis, Sayles & Company's 13F filing for Q3 2024, filed 13 Nov 2024.